The number of Chinese infected people has increased, but the ＂one medicine is difficu

(Beijing Bloomberg) With the surge in crown diseases from all over China, antiviral drugs such as PAXLOVID produced by Pfizer were short of stock, forcing the public to turn to the black market to buy medicines.

According to Bloomberg, China's crown disease is severe, the demand for virus drugs has surged, and the "one medicine is difficult to find" in pharmacies and hospitals in various places.People have sought online sales channels to buy medicines, including purchasing generic drugs that are produced elsewhere, but have not been allowed to sell in China.

A netizen said on Weibo that she was buying Paxlovid's oral medicine produced by Bangladesh, because an elderly relative could not buy medicine in China.She said that although I heard that China's imports of tens of thousands of boxes of paxlovid, "the general public can't get this medicine."Her post has been deleted.

Another netizen calls on the government to make the people get antiviral faster.The netizen shared an advertisement for the Indian PAXLOVID crown disease. On the day of the public paid, the seller was shipped, and the public could receive the goods within two to three weeks.

Those who buy the medicine should shrink the purse.The 21st Century Business Herald reported that a white -collar worker in Guangdong bought a box of paxlovid through the channel purchased by Hong Kong purchased through the channels purchased by Hong Kong, which was more than double the price of mainland China.

Hu Xijin, the former editor -in -chief of the Global Times, also complained that the price of medicines is too high, and expressed hope that Pfizer can reduce the sales price of Chinese crown diseases.He said on Twitter: "It's too expensive, the Chinese people are dissatisfied."

Siddharth Sridhar, a professor of clinical assistant professor at the Department of Microbiology at the University of Hong Kong, said that even if Paxlovid's inventory is enough to meet the needs of China's huge population, "the distribution facilities sent these medicines to patients in time cannot be established overnight"

On the other hand, Biontech, a German biotech company, said on Thursday that the 1500 dose of vaccine has arrived in China on Wednesday and was only for vaccination in Chinese Germans in the early days.Reuters reports that this is believed to be the first foreign vaccine to arrive in China.